Mirae Asset Global Investments’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.96K | Buy |
4,428
+486
| +12% | +$544 | ﹤0.01% | 1541 |
|
|
2025
Q1 | $3.35K | Buy |
3,942
+147
| +4% | +$125 | ﹤0.01% | 1526 |
|
|
2024
Q4 | $6.11K | Buy |
+3,795
| New | +$6.11K | ﹤0.01% | 1545 |
|
|
2024
Q2 | – | Sell |
-58,835
| Closed | -$356K | – | 1867 |
|
|
2024
Q1 | $356K | Buy |
+58,835
| New | +$356K | ﹤0.01% | 2041 |
|
|
2023
Q3 | – | Sell |
-71,679
| Closed | -$342K | – | 2596 |
|
|
2023
Q2 | $342K | Sell |
71,679
-20,342
| -22% | -$97K | ﹤0.01% | 2125 |
|
|
2023
Q1 | $525K | Buy |
92,021
+25,198
| +38% | +$144K | ﹤0.01% | 1895 |
|
|
2022
Q4 | $674K | Buy |
66,823
+8,638
| +15% | +$87.2K | ﹤0.01% | 1720 |
|
|
2022
Q3 | $1.3M | Buy |
58,185
+2,659
| +5% | +$59.6K | ﹤0.01% | 1338 |
|
|
2022
Q2 | $1.38M | Buy |
55,526
+29,785
| +116% | +$738K | ﹤0.01% | 1261 |
|
|
2022
Q1 | $998K | Buy |
25,741
+4,411
| +21% | +$171K | ﹤0.01% | 1326 |
|
|
2021
Q4 | $1.25M | Buy |
21,330
+3,688
| +21% | +$216K | ﹤0.01% | 1234 |
|
|
2021
Q3 | $1.05M | Buy |
17,642
+3,498
| +25% | +$207K | ﹤0.01% | 1282 |
|
|
2021
Q2 | $1.23M | Buy |
14,144
+2,011
| +17% | +$175K | ﹤0.01% | 1195 |
|
|
2021
Q1 | $1M | Buy |
+12,133
| New | +$1M | ﹤0.01% | 1126 |
|